Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Nunes

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaRaquel Nunes, Tal Sella, Kai Treuner, et al.
Frontiers in Neurology|November 16, 2020
Patients and Health Professional's Perspective of Functional Mobility in Parkinson's DiseaseRaquel Bouça-Machado, Nilza Gonçalves, Inês Lousada, et al.
Sensors (Basel, Switzerland)|November 25, 2023
Characterization of Functional Coatings on Cork Stoppers with Laser-Induced Breakdown Spectroscopy ImagingMiguel F S Ferreira, Diana Guimarães, Rafaela Oliveira, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Future Oncology (London, England)|February 28, 2025
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancerErika P Hamilton, Sibylle Loibl, Thomas Bachelot, et al.
Clinical Breast Cancer|January 25, 2022
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair GenesElaine M Walsh, Neha Mangini, John Fetting, et al.
NPJ Breast Cancer|April 22, 2022
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuationKaren Lisa Smith, Neha Verma, Amanda L Blackford, et al.
JCO Oncology Practice|September 21, 2023
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone AppKaren Lisa Smith, Hua-Ling Tsai, David Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline UpdateNeelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaRaquel Nunes, Tal Sella, Kai Treuner, et al.
Frontiers in Neurology|November 16, 2020
Patients and Health Professional's Perspective of Functional Mobility in Parkinson's DiseaseRaquel Bouça-Machado, Nilza Gonçalves, Inês Lousada, et al.
Sensors (Basel, Switzerland)|November 25, 2023
Characterization of Functional Coatings on Cork Stoppers with Laser-Induced Breakdown Spectroscopy ImagingMiguel F S Ferreira, Diana Guimarães, Rafaela Oliveira, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Future Oncology (London, England)|February 28, 2025
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancerErika P Hamilton, Sibylle Loibl, Thomas Bachelot, et al.
Clinical Breast Cancer|January 25, 2022
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair GenesElaine M Walsh, Neha Mangini, John Fetting, et al.
NPJ Breast Cancer|April 22, 2022
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuationKaren Lisa Smith, Neha Verma, Amanda L Blackford, et al.
JCO Oncology Practice|September 21, 2023
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone AppKaren Lisa Smith, Hua-Ling Tsai, David Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline UpdateNeelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
Pageof 10